Market closedNon-fractional
Capricor/CAPR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Capricor
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Ticker
CAPR
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
San Diego, United States
Employees
102
Website
www.capricor.com
Capricor Metrics
BasicAdvanced
$142M
Market cap
-
P/E ratio
-$0.86
EPS
3.97
Beta
-
Dividend rate
Price and volume
Market cap
$142M
Beta
3.97
Financial strength
Current ratio
1.57
Quick ratio
1.527
Long term debt to equity
6.778
Total debt to equity
10.963
Management effectiveness
Return on assets (TTM)
-31.65%
Return on equity (TTM)
-197.34%
Valuation
Price to revenue (TTM)
4.627
Price to book
7.59
Price to tangible book (TTM)
7.59
Price to free cash flow (TTM)
-3.762
Growth
Revenue change (TTM)
389.30%
Earnings per share change (TTM)
-26.63%
3-year revenue growth (CAGR)
447.22%
3-year earnings per share growth (CAGR)
-0.20%
What the Analysts think about Capricor
Analyst Ratings
Majority rating from 5 analysts.
Capricor Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$4.9M
-59.17%
Net income
-$9.7M
1,285.71%
Profit margin
-197.95%
3,295.37%
Capricor Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.29
-$0.25
-$0.02
-$0.31
-
Expected
-$0.35
-$0.29
-$0.09
-$0.11
-$0.36
Surprise
-17.14%
-13.79%
-77.78%
173.53%
-
Capricor News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Capricor stock?
Capricor (CAPR) has a market cap of $142M as of July 26, 2024.
What is the P/E ratio for Capricor stock?
The price to earnings (P/E) ratio for Capricor (CAPR) stock is 0 as of July 26, 2024.
Does Capricor stock pay dividends?
No, Capricor (CAPR) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next Capricor dividend payment date?
Capricor (CAPR) stock does not pay dividends to its shareholders.
What is the beta indicator for Capricor?
Capricor (CAPR) has a beta rating of 3.97. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Capricor stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.